Transperitoneal implantation of mouse ascites hepatoma MH 134, and transperitoneal or transurethral implantation of rat ascites tumor, Yoshida sarcoma and AH 130, were performed on the urinary bladder of the same strain animals, and following results were obtained. The bladder tumor was developed in high rate with the transperitoneal implantation, while it was produced in the rate of 27.3-54.5% with the transurethral method. The tumor cell was at first embedded in the mucosal layer, then infiltrated with rapid multiplication along the vesical wall invading some contiguous tissues, and thus the typical bladder tumor was produced. The occurrence of ascites had showed some difference between the kinds of tumor cell implanted. And it was found in 25.6-50.0% of the case in which the transperitoneal implantation was performed, while there could not be found any ascites in the case with transurethral implantation. The hy droureter was found in a half of the cases in which the implantation of tumor cell was performed, and the occurrence rate of it was rather correspondent to the duration after the implantation. And it was assumed that this reveal the invasion of the produced tumor upon the ureteral orifice just as in the clinical cases.
are made to elucidate the mechanism of the carcinogenesis from the experimental basis, using various agents. Because of the unreliable reproductivity of the method, this approach cannot be relied upon for the study of the pathophysio logical aspect of bladder cancer and the mechanism of carcinogenesis7-9).
For these reasons, we have made experimental bladder tumor in rats and mice by the transplantation of ascitic tumor cells and several investigations have been done.
This paper reports the method of the transplantation of the tumor cells into the urinary bladder and the results obtained with our method are also presented.
MATERIALS AND METHODS
Materials
Both female and male Donryu rats with average body weight of 150 gm, and C3H strain mice with average body weight of 25 gm were used throughout this experiment. Only the female rats were used when ascitic tumor cells were injected into the bladder through urethral catheterization.
Three different kinds of ascitic tumors were used, namely MH 134 hepatoma, Yoshida sarcoma, and AH 130 hepatoma.
The suture materials ordinarily used in eye surgery were applied.
Methods

1) Transabdominal implantation of the ascites tumor into the bladder
Animals were anesthesized with ether and fixed on the surgical board in supine position. After ordinary preoperative preparation, median hypogastric incision was made and urinary bladder was exposed. The bladder was then brought out through the incision wound. The suspending threads, 001 black silk thread with needle which is commonly used in the ophthalmic operation, were fixed symmetrically on both sides of the bladder about 0.3 cm. below the top (Fig. 1) . These threads were used to close the bladder wall after the tumor implantation and served afterward as the marking of the place of the transplantation. Suspending the bladder by these threads, through the top of the bladder, 0.03 ml. of ascitic fluid which had been taken from animals bearing ascitic tumor and kept in syringe previous to the surgery, was injected (Fig. 2) . The ascitic fluid was not diluted. Immediately after the withdrawal of the needle, the leakage of the ascitic fluid was prevented by picking up the locus of the injection by pincette and pulling down the suspending threads around the pincette and then tying them. Abdominal wound was then closed by double layer sutures using nylon threads.
2) Transabdominal implantation of the tumor mass into the bladder Ascitic tumor was implanted into the back of animals of the same strain of the host animal before the procedure. This tumor tissue was then used for the transplantation into the bladder. The procedure differs from the above mentioned method only in that a small incision was made in between the two suspending threads. A tumor tissue, 0.2 cm. in diameter, was removed from the back of the animal pre-treated as above and transplanted into the bladder of the other animals of the same strain.
3) Implantation through urethral catheter Female rats were anesthesized by ether. A vinyl tube, 1 mm. in diameter, was used for the catheter. A wire was placed in the vinyl tube so that the cathter could be bent slightly to help the insertion into the bladder. Extreme care was necessary not to damage the urethra, as well as possible intraperitoneal penetration. After some practice, successful catheterization could be accomplished in about 70% of cases. 0.04 ml. of ascitic tumor was then injected through the catheter.
EXPERIMENTAL RESULTS
A. The tumor mass implanted was taken from the tumor tissue which was produced by the insertion of the tumor cells into the back of the other animals of the same strain during 10 days. changes especially in those taken from the under part of the baadder. The mu cosal membrane was usually intact and tumor cell infiltration was limited in the submucosa and in the muscular layer, proliferating into clusters and expanding into surrounding tissues (Fig. 4) . In one case, necrotizing tumor mass was observed in the lumen of the bladder, and part of the mass clinging to the mucosal membrane was the membrane which lost its normal pattern, and large focus of the tumor cells was found just below the membrane (Fig. 5 ). This was thought to be the originally implanted tumor mass and demonstrating typical pattern of the inva sion of the implanted tumor cells penetrating through the mucosal membrane. some parts, tumor cell infiltration could be seen in these mucosal layer . In short, the changes observed in the mucosa resembled the malignancy developing from mucosal membrane (Fig. 6 ). Specimen taken from around the internal orifice of the urethra revealed normal mucosal membrane, but well developed tumor cell infiltration was observed in the submucosa as well as in the muscular layer where tumor cells were more advanced in the degree of atypia, and interstitial tissues inside the tumor mass increased more than those observed in the main focus of the implanted tumor.
In the animals sacrificed on the 14th experimental day, tumefaction of the tumor was more pronounced, an expanding tumor mass almost obliterating the bladder cavity, and partly projecting into the lumen of the bladder through the locus where the mucosal menbrane was destroyed. The tumor mass implanted was taken from the tumor tissue which was produced by the insertion of the tumor cells into the back of the other animals of the same strain during 5 days. Histological examinations lined up the macroscopic findings and the changes noted were much severer than those of MH 134 hepatoma experiments. In group A, infiltration of the tumor cells was found to spread into all area of specimens, and almost of all mucosal membrane was destroyed, showing malignant changes (Fig. 8) . In some parts of tumor cell clusters in submucosal area and in muscular layer, necrosis was found. In group B, tumor cell infiltration spreaded outwards involving the muscular layer and surrounding adipose tissue as well.
2) Ascites tumor injection experiment
Ascitic tumor used in this experiment was taken from animals in which intraperitoneal ascitic tumor implantation was done 5 to 7 days prior to the experiment.
In all of 10 rats subjected to the experiment the tumor implantation was successfully done (Table  ‡Z) . Aseites was found only in 5 rats sacrificed on the 14th experimental day. Hydroureter occurred in a total of 9 animals (90.0%); in 4 of those killed on the 7th experimental day (80.0%) and in all of those sacrificed on the 14th experimental day. Enlargement of retroperitoneal lymph nodes was found in all of animals. Histological findings observed on the specimen taken from the central part of the bladder revealed severe malignant changes consisting of almost complete lack of normal mucosal membrane which was replaced by tumor cells, narrowing of the bladder cavity, and submucosal and intramural tumor cell infiltration.
Specimens obtained from the area close to the internal urethral orifice and from the top of the bladder revealed well preserved normal mucosa and submucosal to intramural tumor cell infiltration associated with round cell infiltration.
In the group sacrificed on the 14th experimental day, more pronounced changes were observed. Tumor cell infiltration was seen to extend through the muscular layer to surrounding tissues, and normal bladder tissue was seen only as the remnant . The tumor mass implanted was taken from the tumor tissue which was produced by the insertion of the tumor cells into the back of the other animals of the same strain during 7 days. no adhesion with the surrounding prostatic gland or the seminal vesicles was obser ved (Fig. 9) . Ascites formation was observed only in one rat sacrificed on the 7th experimental day (20.0%) and in another one killed on the 14th experimental day (33.3%) ; i.e., in a total of 2 animals (25.0%) . Hydroureter occurred in 3 animals killed on the 7th experimental day (60.0%), and in all of 3 animals sacri ficed on the 14th experimental day; i.e., in a total of 6 (75.0%). Retroperitoneal lymph nodes were, however, enlarged in all animals (Table IX) . Histological findings in the animals killed on the 7th experimental day revealed a tumor mass located in the mucous membrane or submucosal area.
Mucosal membrane in some parts fell off and in some parts the tumor cell infiltration proliferated so as to show tumor-like projection . Occasionally submucosal clusters of tumor cells were found (Fig . 10) . In the animals sacrificed on the 14th experimental day, histological examination revealed central necrosis of these submucosal clusters as well as outwards spreading of tumor cell infiltration. Partial defect of mucosal membrane and tumorous projection of the surround ing mucosa were found by histological examination. Submucosal to intramural cluster formation of tumor cells and infiltration were also noted. In the animals killed on the 14th experimental day, the defect of mucosal membrane was much wider and projection of tumorous membrane resembled that of papillary carcinoma. Submucosal cluster formation was also noted and infiltration reached into perivesical tissues.
Summary of the section
Excluding the experiment where AH 130 tumor was used, implantation of tumor was done successfully in 100%. There was no difference between the experimental procedures either using tumor tissue transplantation or ascitic tumor injection, although the incidence of ascites formation and hydroureter differed in each of the experimental setup. Ascites occurred in the experiments where MH 134 was used in 35.7 to 41.2%, in Yoshida sarcoma experiments in 40 to 50%, and AH 130 experiments in 25 to 28.6%. This tendency was thought to be correlated with the severity of tumorous process observed macroscopically. Ascites seems to be more frequently occurring in those animals which received by ascitic tumor injection technique than those animals which received tumor tissue transplantation (Table ? ).
The time of experiment might apparently play a role; the longer the time elapsed the higher the incidence of ascites (Table   ? ). The incidence of hydroureter was found to be 64.3 to 64.7% in MH 134 experiments, 40 to 90.0% in Yoshida sarcoma animals, and 42.9 to 75.0% in AH 130 implantation animals. No significant difference was observed in these groups. Differnce of the technique of implantation showed no variation of the incidence of hydroureter in MH 134 group but in Yoshida sarcoma and AH 130 ascitic tumor injection groups and tumor tissue transplantation groups were, respectively, found to be high in the incidence. The longer the experimental time, the higher the incidence. This suggests that the size of the tumor mass is of some importance. Histologically the severest findings were obtained in the Yoshida sarcoma groups. Time might play, here again, an important role ; the longer the duration of the experimental course the severer the findings. In the ascitic tumor in jection group, histological findings were severer than in the other group. The form and degree of the infiltration of tumor cells, however, differed from group to group. In MH 134 group, for instance, in the animals to which injection technique was applied, stratification and tumor cell infiltration in the mucous membrane were demonstrated, and in tumor tissue transplanted group, practically no changes of the mucosal membrane was noted although submucosal changes were more pronounced. In Yoshida sarcoma group, the mucosal membrane showed almost total destruction or was occupied by tumor cells ; submucosal cluster formation was more striking, and tumor cell infiltration into the surroun ding tissues was more extensive. In AH 130 group, the mucosal membrane was damaged and partly replaced by tumor, and in some parts, projection of the tumourous membrane into the vesical lumen was found.
B. Intra-vesicular implantation through catheterization
Yoshida sacroma
Experiments were done in 18 rats. In 10 rats, namely in 55.6%, implanta tion was successful; generally, in these animals, the tumor developed by implanta tion took milder form, actually in 3 out of these 10 animals, the presence of the tumor was verified only after a careful histological examination.
As shown in Fig. 11 , however, in some animals higher grade of development 
AH 130 hepatoma
In 3 out of 11 animals the implantation was successfully done (27 .3%). Thus transplanted tumor took rather a mild form , in 2 of these animals, only a swelling of the bladder wall was noted, although in another animal , a tumor of the small finger tip size was found. Ascites was not found in these animals but hydroureter of mild degree was found in 2 animals . Retroperitoneal lymph nodes enlarged in all of these three animals (Table XIV) .
Histological examinations revealed, in these animals , changes of the mucosal membrane to be the main finding. Papillomatous projection of the membrane was found as is shown in Fig. 13 , in some of specimens . Extent of tumor cell infiltra tion was limited in the submucosal area. These findings suggest that in these type of implantation, the tumor grows in the mucosal membrane or on the surface of the mucosal membrane, then gradually infiltrat into deeper tissues.
Summary of the section
Comparison between the Yoshida sarcoma group and All 130 hepatoma group reveals that the rate of successful implantation is high in Yoshida sarcoma group, as 55.6% against 27.3% found in AH 130 tumor group, although in both groups, if compared to that of transabdominal implantation group, the rate of successful implantation was significantly lower. Ascites was never found in this group, but hydroureter was found in animals sacrificed after the 14th experimental day. Histologically, in this group, the tumor took a mild form. In AH 130 tumor group, the strong changes observed in the mucosal membrane resembling papillom atous process were thought to be noteworthy.
DISCUSSION
Numerous experimental ascitic tumor are now available starting from the carcinoma Ehrlich reported as the first of this kind10). In 1952, Dunham and Stewart11) reported total of 243 strains being available for transplantation experiments. In Japan, after the introduction of Yoshida sarcoma strain in 1943, available experimental tumor are developing12,13). Consequently, there were numerous experiments done in this field14-17). However, rather a few reports were available on the experiments regarding the direct implantation of ascitic tumor into various animal organs such as described by Sawada18), Mizota et al. 19 and after three successive sprays in 85.4%. In rats, after three successive sprays of tumor cells, Yoshida sarcoma was taken by the lung in 96.0%, AH 66 F in 100%, and in AH 13 in 88.0%. Matsukado et al. implanted MH 134 tumor cells, using 2 million, half million and 200,000 times diluted ascitic tumor fluid, into the vaginal mucosa of mice. Implantation was successfully made in the groups of 2 million times dilution group in 100.0%, in half million times dilution group in 92.0%, and in the group of 20,000 times dilution group in 23.0%.
In our experiments, the main purpose is to make an implantation of tumor cell into the mucosal membrane of the bladder, thus the implantation of ascitic tumor cells or that of tumorous tissues into the bladder were attempted.
The transperitoneal implantation was successfully done in almost all of cases excluding when the AH 130 tumor ascites was used.
There was no significant difference between the redults of the experiments whether ascitic tumor was used or tumor tissues were used. The rate of the successful implntation was low in the experiments where urethral catheterization was applied as the means of implanting malignancies and showed 55.6% in Yoshida sarcoma and 23.1% in AH 130 hepatoma. This is interesting since the presence of intact mucosal membrane seemingly protected animals from taking implantation of tumor cells such as reported by Sawada et al., and Majima et al. Furthermore, in our experiments, even in the cases of transperitoneal implantation, the materials were implanted in the bladder cavity. According to the findings at autopsy, the tumor cells did not seem to spread through the wound made at the upper part of the bladder. The successful attempt of the implantation through catheterization clearly demonstrated the fact that tumor implantation can be taken in the bladder with intact mucosal membrane. As quoted above, Takahashi et al., reported that, in their transtracheal im plantation experiments of malignant tumors, the histological findings similar to the adenocarcinoma were observed in the lungs of animals where ascitic tumor originated from mammary glands was used and in the animals where Yoshida sarcoma, AH130, AH 66F were used, and the massive infiltration into the both parenchyma and connective tissues of the lung could be demonstrated. Majima et al. reported that in their experiments of MH 134 tumor transplantation into the rectum, tumor cells could be detected only in the mucosal membrane on the 7th day of transplantation, but it penetrated into submucosal and muscular layer and then adjoining tissues as experimental time was prolonged. In our experiments the most severe pathological findings were found in the Yoshida sarcoma implanta tion animals. It was also found that the longer the time elapsed the severer were the pathological findings. There were some differences of the mode of in filtration depending upon the type of the ascitic tumor used in the experiment. In MH 134 animals of tumorous tissue implantation, no mucosal abnormality was ever found. The infiltration was limited in the submucosa in most of the cases. In ascitic tumor cell implantation animals, however, submucosal changes were associated with stratification of the mucosal membrane and mucosal tumor cell infiltration. In Yoshida sarcoma experiments the mucosal membrane and submucosal tissues were both involved, and in AH 130 hepatoma experiments, the mucosal membrane showed cancerous changes as well as the papillomatous changes taking place in some parts of the mucosa where these papillomatous tissues projected into the bladder lumen. In transperitoneal implantation animals, ascites occurred in the rate of 35.7 to 41.2% in MH 134 hepatoma experiments, 40.0 to 50.0% in Yoshida sarcoma experiments, and in 25.0 to 28.6% in AH 130 hepatoma experiments. The longer the experimental time the more frequent was the occurrence of the ascites. No ascites was found in the animals in which tumor cell implantation was attempted through bladder catheterization.
This fact, and the facts that in transperitoneal implantation animals the infiltration of tumor cells into the surrounding tissues was found in the later period of the experiment, and that the longer the time of observation the more frequent was the development of the ascites in this group, strongly suggest that the mechanism of the ascites formation is not due to the unintentional direct implantation of the tumor cells into the peritoneal cavity at the time of transperitoneal implantation or leakage of the tumor cells from the wound of the bladder, but due to the infiltration of the implanted tumor cells through the bladder wall.
Clinical bladder cancer frequently occurrs arround the trigon. This is thought to explain the frequent occurrence of hydroureter due to the infiltration of tumor cells to the ureteral orifice and consequently resulting kidney dysfunction in the involved side. Hydroureter was found in 59 out of 100 cases by Petkovic24), in 76 out of 96 cases by Kickham et al.25) , in 23 out of 47 cases reported by Ichikawa et al.26) and in 7 out of 23 cases of bladder cancer which received partial resection in our department. In our transperitoneal implantation experiments, hydroureter occurred in 64.3 to 64.7% in MH 134 hepatoma group, 40.0 to 90.0% in Yoshida sarcoma group, and 42.9 to 75.0% in AH 130 hepatoma group. The rate increased with the progress of the experimental course. In the animels in which implantation was done through urethral catheterization, hydroureter waso bserved , after 14 days of experiments, in 55.6 to 66.7% of them. This finding is in accordance with the clinical findings suggesting that the tumor cell infiltration arround the ureteral orifice causes the hydroureter.
CONCLUSION
Transperitoneal implantation of MH 134 hepatoma into the bladder and both transperitoneal and transurethral implantations of Yoshida sarcoma and AH 130 hepatoma were attempted in rats. The results obtained were as follows:
1. In MH 134 hepatoma experiments, when the tumor tissue was used for implantation, successful transplantation was done in 14 out of 15 animals (93.3%), and when ascitic fluid was used the experiment was successful in 100%. In Yoshida sarcoma experiment, all implantations were successfully taken . In AH 130 hepatoma experiment, tumor tissue implantation was successfully taken in all animals subjected to the implantation, and when ascitic fluid was used for implantation material the experiments were successful in 7 out of 11 animals , namely in 63.3%.
Transurethral implantation was successfully done in 10 out of 18 animals (55.6%) in Yoshida sarcoma experiment, and in 3 out of 11 animals (27.3%) when AH 130 hepatoma was used. 2. Macroscopic findings in transabdominal implantation groups demon strated tumorous enlargement of the bladder; the findings were most pronounced in Yoshida sarcoma experiment and more so in the cases kept longer after the implantation. In animals which were subjected to the transurethral implanta tion, the macroscopic findings were milder, especially in AH 130 hepatoma experiment where the hyperplasia of the bladder wall was the only finding.
3. Histological characteristics of the implanted tumor differed according to the method of the implantation and to the original tumor used.
In MH 134 hepatoma tissue transplantation experiments, changes observed were limited in the submucosa, and in ascitic fluid implantation animals, stratified mucosal membrane and intramucosal tumor cell infiltration were demonstrated. In Yoshida sarcoma experiments, both tissue implantation and ascitic fluid implantation, a partial falling off of the mucosa or tumorous changes in the mucosa accompanied with submucosal changes were demonstrated. In AH 130 hepatoma experiments, sloughing of the mucosa and tumorous changes of the mucosa as well as the papillomatous production of the mucosa into the bladder lumen were observed. The most severe changes were noted in Yoshida sarcoma experiment group; the longer the time of the experiment the more pronounced the finding.
4. Ascites occurred, in transperitoneal implantation experiments, in 35.7 to 41.2% in MH 134 hepatoma experiments, in 40.0 to 50.0% in Yoshida sarcoma experiments, and in 25.0 to 28.6% in AH 130 hepatoma experiments. When ascitic fluid was used for implantation material, the rate of occurrence of the ascites was higher than that in the experiments where tumor tissues were used. The longer the animals were kept after the transplantation, the higher the rate of occurrence of the ascites. No ascites formation was ever noted in the groups of animal subjected to the transurethral implantation.
5. In transperitoneal implantation experiments, hydroureter occurred in 64.3 to 64.7% in MH 134 hepatoma group, 40.0 to 90.0% in Yoshida sarcoma group, and in 42.9 to 75.0% in AH 130 hepatoma group. The extent of the developed hydroureter was apparently depending upon the length of time following the implantation. The development of hydroureter was observed, in cases of transurethral implantation, only in those animals kept more than 14 days after the implantation. In these animals hydroureter appeared in 55.6% in Yoshida sarcoma group and in 66.7% in AH 130 hepatoma group. The tumor-like swelling of the urinary bladder is observed. Fig. 7 . The macroscopic finding of the urirary bladder following the insertion of the tumor mass of Yoshida sarcoma.
The fused tumor including the rrinary bladder, the prosl.nte, and the seminal vesicles, is shown. The bladder tumor about 1 cm in diameter is shown. 
